Azilsartan medoxomil
- Generic Name
- Azilsartan medoxomil
- Brand Names
- Edarbyclor, Edarbi
- Drug Type
- Small Molecule
- Chemical Formula
- C30H24N4O8
- CAS Number
- 863031-21-4
- Unique Ingredient Identifier
- LL0G25K7I2
- Background
Azilsartan medoxomil is a prodrug that is broken down to azilsartan, which belongs in the angiotensin-receptor blocking (ARB) drug class. It is a selective AT1 subtype angiotensin II receptor antagonist. Azilsartan medoxomil is a relatively recently-developed antihypertensive drug that was first approved by the FDA in February 2011. Many guidelines recommend...
- Indication
Azilsartan medoxomil is indicated for the treatment of hypertension to lower blood pressure in patients over 18 years of age. It may be used either alone or in combination with other antihypertensive agents. Some antihypertensive drugs have lesser effects on blood pressure in black patients.
...
- Associated Conditions
- Albuminuria, Hypertension, Atrial Fibrillation
- Associated Therapies
- -
Efficacy and Safety of Azilsartan in Subjects With Essential Hypertension
- First Posted Date
- 2008-09-25
- Last Posted Date
- 2010-06-22
- Lead Sponsor
- Takeda
- Target Recruit Count
- 555
- Registration Number
- NCT00759551
An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension.
- Conditions
- Interventions
- First Posted Date
- 2008-06-12
- Last Posted Date
- 2011-04-19
- Lead Sponsor
- Takeda
- Target Recruit Count
- 1291
- Registration Number
- NCT00696436
A Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential Hypertension
- First Posted Date
- 2008-06-12
- Last Posted Date
- 2012-01-04
- Lead Sponsor
- Takeda
- Target Recruit Count
- 418
- Registration Number
- NCT00696384
Efficacy and Safety Comparison of Azilsartan Medoxomil to Valsartan in Participants With Essential Hypertension
- First Posted Date
- 2008-01-11
- Last Posted Date
- 2012-02-02
- Lead Sponsor
- Takeda
- Target Recruit Count
- 984
- Registration Number
- NCT00591578
Efficacy and Safety of Azilsartan Medoxomil in African American Participants With Essential Hypertension
- First Posted Date
- 2008-01-11
- Last Posted Date
- 2011-04-19
- Lead Sponsor
- Takeda
- Target Recruit Count
- 413
- Registration Number
- NCT00591253
Safety and Efficacy of Azilsartan Medoxomil in Participants With Mild to Moderate Hypertension
- Conditions
- Interventions
- First Posted Date
- 2006-08-09
- Last Posted Date
- 2011-04-19
- Lead Sponsor
- Takeda
- Target Recruit Count
- 449
- Registration Number
- NCT00362115
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.